Human leukocyte antigen class II (DRB1 and DQB1) alleles frequencies in patients with various forms of pemphigus among the Russian population

Abstract

BACKGROUND: Autoimmune bullous dermatoses are known to be the most severe blistering conditions of skin. HLA-DRB1 and DQB1 alleles might play a crucial role in their onset. In pemphigus HLA class II molecules stimulate the division of T helper cells, which in turn stimulate B cells to produce antibodies to epidermal keratinocytes causing acantholysis. The HLA-DRB1 and DQB1 alleles’ frequencies studied in pemphigus in a vast variety of populations worldwide. However, as of yet, this mechanism was not investigated in Russian population.

AIM: To estimate the prevalence of the HLA-DRB1 and DQB1 alleles at a low- and high-resolution levels in patients with various forms of pemphigus. We observed 86 patients with pemphigus vulgaris, 13 ― with pemphigus foliaceus, 6 patients with paraneoplastic pemphigus and 92 healthy volunteers.

MATERIALS AND METHODS: HLA typing for DRB1 and DQB1 was performed with 50 nanogram DNA extraction and polymerase chain reaction.

RESULTS: At a low-resolution level HLA-DRB1*4 and DRB1*14 alleles were statistically significant more frequent in pemphigus vulgaris and pemphigus foliaceus patients compared to those in control subjects, whereas HLA-DRB1*11, DRB*16, and DRB1*3 alleles were more frequent in healthy volunteers. At a high-resolution level, DRB1*04:02 allele was observed to show its statistically significant higher frequency in all variants of pemphigus, including paraneoplastic pemphigus. However, DRB1*14:05 HLA allele was more frequent in pemphigus vulgaris and pemphigus foliaceus patients, whereas DRB1*11:04 one was found to be 3.7 times more frequent in healthy controls. Additionally, at a low-resolution level for HLA-DQB1 alleles no statistically significant results were observed. However, at a high-resolution level the chances for more frequent indication of DQB1*03:02 allele were 7.09 times higher in pemphigus foliaceus group and 2.49 higher in pemphigus vulgaris patients compared to healthy volunteers. Moreover, DQB1*05:03 was identified more frequently in pemphigus vulgaris and paraneoplastic pemphigus groups of patients, whereas DQB1*03:01 allele was shown to be increased in the group of healthy donors.

CONCLUSION: HLA-DRB1*4, DRB1*14, DRB1*04:02, DRB1*14:05, DQB1*03:02 and DQB1*05:03 alleles might be considered as the genetic markers for pemphigus vulgaris susceptibility, while HLA-DRB1*11, DRB*16, DRB1*3, DRB1*11:04 and DQB1*03:01 allelic groups appear to be protective for Russian population.

Keywords

HLA DRB1 alleles / HLA DQB1 alleles / pemphigus

References

[1] Shams S, Amirzargar AA, Yousefi M, et al. HLA class II (DRB, DQA1 and DQB1) allele and haplotype frequencies in the patients with pemphigus vulgaris. J Clin Immunol. 2009;29(2):175–179. doi: 10.1007/s10875-008-9244-x

[2] Shams S., Amirzargar A.A., Yousefi M., et al. HLA class II (DRB, DQA1 and DQB1) allele and haplotype frequencies in the patients with pemphigus vulgaris // J Clin Immunol. 2009. Vol. 29, N 2. P. 175–179. doi: 10.1007/s10875-008-9244-x

[3] Pollmann R, Schmidt T, Eming R, Hertl M. Pemphigus: A comprehensive review on pathogenesis, clinical presentation and novel therapeutic approaches. Clin Rev Allergy Immunol. 2018;54(1):1–25. doi: 10.1007/s12016-017-8662-z

[4] Pollmann R., Schmidt T., Eming R., Hertl M. Pemphigus: A comprehensive review on pathogenesis, clinical presentation and novel therapeutic approaches // Clin Rev Allergy Immunol. 2018. Vol. 54, N 1. P. 1–25. doi: 10.1007/s12016-017-8662-z

[5] Li S, Zhang Q, Wang P, et al. Association between HLA-DQB1 polymorphisms and pemphigus vulgaris: A meta-analysis. Immunol Invest. 2018;47(1):101–112. doi: 10.1080/08820139.2017.1385622

[6] Li S., Zhang Q., Wang P., Li J., et al. Association between HLA-DQB1 polymorphisms and pemphigus vulgaris: A meta-analysis // Immunol Invest. 2018. Vol. 47, N 1. P. 101–112. doi: 10.1080/08820139.2017.1385622

[7] Haase O, Alneebari R, Eldarouti MA, et al. Association with HLA-DRB1 in Egyptian and German pemphigus vulgaris patients. Tissue Antigens. 2015;85(4):283–286. doi: 10.1111/tan.12519

[8] Haase O., Alneebari R., Eldarouti M.A., et al. Association with HLA-DRB1 in Egyptian and German pemphigus vulgaris patients // Tissue Antigens. 2015. Vol. 85, N 4. P. 283–286. doi: 10.1111/tan.12519

[9] Maehara L, De-Souza-Santana FC, Porro AM, et al. HLA class II alleles of susceptibility and protection in Brazilian and Dutch pemphigus foliaceus. Br J Dermatol. 2018;178(3):e212–e214. doi: 10.1111/bjd.16022

[10] Maehara L., De-Souza-Santana F.C., Porro A.M., et al. HLA class II alleles of susceptibility and protection in Brazilian and Dutch pemphigus foliaceus // Br J Dermatol. 2018. Vol. 178, N 3. P. e212–e214. doi: 10.1111/bjd.16022

[11] Dere G, Yavuz IH, Ozaydın Yavuz G, et al. Assessment of HLA-A, HLA-DR, and HLA-DQ alleles in patients with pemphigus vulgaris from eastern of Turkey. J Cosmet Dermatol. 2020;19(9):2432–2437. doi: 10.1111/jocd.13298

[12] Dere G., Yavuz I.H., Ozaydın Yavuz G., et al. Assessment of HLA-A, HLA-DR, and HLA-DQ alleles in patients with pemphigus vulgaris from eastern of Turkey // J Cosmet Dermatol. 2020. Vol. 19, N 9. P. 2432–2437. doi: 10.1111/jocd.13298

[13] Bhol KC, Rojas AI, Khan IU, Ahmed AR. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid. Cytokine. 2000;12(7):1076–1083. doi: 10.1006/cyto.1999.0642

[14] Bhol K.C., Rojas A.I., Khan I.U., Ahmed A.R. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid // Cytokine. 2000. Vol. 12, N 7. P. 1076–1083. doi: 10.1006/cyto.1999.0642

[15] Satyam A, Khandpur S, Sharma VK, Sharma A. Involvement of T(H)1/T(H)2 cytokines in the pathogenesis of autoimmune skin disease-Pemphigus vulgaris. Immunol Invest. 2009;38(6):498–509. doi: 10.1080/08820130902943097

[16] Satyam A., Khandpur S., Sharma V.K., Sharma A. Involvement of T(H)1/T(H)2 cytokines in the pathogenesis of autoimmune skin disease-Pemphigus vulgaris // Immunol Invest. 2009. Vol. 38, N 6. P. 498–509. doi: 10.1080/08820130902943097

[17] Li S, Zhang Q, Wang P, et al. Association between HLA-DQB1 polymorphisms and pemphigus vulgaris: A meta-analysis. Immunol Invest. 2018;47(1):101–112. doi: 10.1080/08820139.2017.1385622

[18] Li S., Zhang Q., Wang P., et al. Association between HLA-DQB1 polymorphisms and pemphigus vulgaris: A meta-analysis // Immunol Invest. 2018. Vol. 47, N 1. P. 101–112. doi: 10.1080/08820139.2017.1385622

[19] Louis TA, Zeger SL. Effective communication of standard errors and confidence intervals. Biostatistics. 2009;10(1):1–2. doi: 10.1093/biostatistics/kxn014

[20] Louis T.A., Zeger S.L. Effective communication of standard errors and confidence intervals // Biostatistics. 2009. Vol. 10, N 1. P. 1–2. doi: 10.1093/biostatistics/kxn014

[21] Vuong TB, Do DM, Ong PT, Thanh Le TV. HLA-DRB1 and DQB1 genetic susceptibility to pemphigus vulgaris and pemphigus foliaceus in Vietnamese patients. Dermatol Reports. 2021;14(2):9286. doi: 10.4081/dr.2021.9286

[22] Vuong T.B., Do D.M., Ong P.T., Thanh Le T.V. HLA-DRB1 and DQB1 genetic susceptibility to pemphigus vulgaris and pemphigus foliaceus in Vietnamese patients // Dermatol Reports. 2021. Vol. 14, N 2. P. 9286. doi: 10.4081/dr.2021.9286

[23] Brochado MJ, Nascimento DF, Campos W, et al. Differential HLA class I and class II associations in pemphigus foliaceus and pemphigus vulgaris patients from a prevalent Southeastern Brazilian region. J Autoimmun. 2016;(72):19–24. doi: 10.1016/j.jaut.2016.04.007

[24] Brochado M.J., Nascimento D.F., Campos W., et al. Differential HLA class I and class II associations in pemphigus foliaceus and pemphigus vulgaris patients from a prevalent Southeastern Brazilian region // J Autoimmun. 2016. N 72. P. 19–24. doi: 10.1016/j.jaut.2016.04.007

[25] Sáenz-Cantele AM, Fernández-Mestre M, Montagnani S, et al. HLA-DRB1*0402 haplotypes without DQB1*0302 in Venezuelan patients with pemphigus vulgaris. Tissue Antigens. 2007;69(4):318–325. doi: 10.1111/j.1399-0039.2007.00826.x

[26] Sáenz-Cantele A.M., Fernández-Mestre M., Montagnani S., et al. HLA-DRB1*0402 haplotypes without DQB1*0302 in Venezuelan patients with pemphigus vulgaris // Tissue Antigens. 2007. Vol. 69, N 4. P. 318–325. doi: 10.1111/j.1399-0039.2007.00826.x

[27] Párnická Z, Švecová D, Javor J, et al. High susceptibility to pemphigus vulgaris due to HLA-DRB1*14:54 in the Slovak population. Int J Immunogenet. 2013;40(6):471–475. doi: 10.1111/iji.12052

[28] Párnická Z., Švecová D., Javor J., et al. High susceptibility to pemphigus vulgaris due to HLA-DRB1*14:54 in the Slovak population // Int J Immunogenet. 2013. Vol. 40, N 6. P. 471–475. doi: 10.1111/iji.12052

[29] Loiseau P, Lecleach L, Prost C, et al. HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus. J Autoimmun. 2000;15(1):67–73. doi: 10.1006/jaut.2000.0388

[30] Loiseau P., Lecleach L., Prost C., et al. HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus // J Autoimmun. 2000. Vol. 15, N 1. P. 67–73. doi: 10.1006/jaut.2000.0388

[31] Martel P, Gilbert D, Busson M, et al. Epistasis between DSG1 and HLA class II genes in pemphigus foliaceus. Genes Immun. 2002;3(4):205–210. doi: 10.1038/sj.gene.6363839

[32] Martel P., Gilbert D., Busson M., et al. Epistasis between DSG1 and HLA class II genes in pemphigus foliaceus // Genes Immun. 2002. Vol. 3, N 4. P. 205–210. doi: 10.1038/sj.gene.6363839

[33] Yamashina Y, Miyagawa S, Kawatsu T, et al. Polymorphisms of HLA class II genes in Japanese patients with pemphigus vulgaris. Tissue Antigens. 1998;52(1):74–77. doi: 10.1111/j.1399-0039.1998.tb03026.x

[34] Yamashina Y., Miyagawa S., Kawatsu T., et al. Polymorphisms of HLA class II genes in Japanese patients with pemphigus vulgaris // Tissue Antigens. 1998. Vol. 52, N 1. P. 74–77. doi: 10.1111/j.1399-0039.1998.tb03026.x

[35] Dendrou CA, Petersen J, Rossjohn J, Fugger L. HLA variation and disease. Nat Rev Immunol. 2018;18(5):325–339. doi: 10.1038/nri.2017.143

[36] Dendrou C.A., Petersen J., Rossjohn J., Fugger L. HLA variation and disease // Nat Rev Immunol. 2018. Vol. 18, N 5. P. 325–339. doi: 10.1038/nri.2017.143

RIGHTS & PERMISSIONS

Eco-Vector